Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Employment test 51 - 200 employees
Company dna potter clarkson llp
operating since 1889
Headquarter in Nottingham and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Andrew John Sanderson has worked on the following 10 EPO patent applications which have been published in the last five years:

EP11736496

DELIVERY OF SELF-REPLICATING RNA USING BIODEGRADABLE POLYMER PARTICLES

IPC classification:
A61K 9/16, A61K 9/51, C12N 15/86, C12N 15/88
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11758014

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11755497

SMALL LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/00, A61K 48/00
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP12769787

PEGYLATED LIPOSOMES FOR DELIVERY OF IMMUNOGEN-ENCODING RNA

IPC classification:
A61K 9/00, A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12738679

LIPOSOMES HAVING USEFUL N:P RATIO FOR DELIVERY OF RNA MOLECULES

IPC classification:
A61K 9/127, A61K 39/39
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
EXAMINATION IN PROGRESS
EP12738311

OIL-IN-WATER EMULSIONS THAT CONTAIN NUCLEIC ACIDS

IPC classification:
A61K 9/127, A61K 39/00
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP12743273

CATIONIC OIL-IN-WATER EMULSIONS

IPC classification:
A61K 9/107, A61K 39/00, A61K 47/06, A61K 47/24
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Antoine Courgeon, Novartis Vaccines and Diagnostics Srl
Status:
GRANT OF PATENT INTENDED
EP14187138

Detoxified Escherichia coli immunogens

IPC classification:
A61K 39/108
Applicant:
Novartis AG
Agent:
Cameron Marshall, Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11736500

LIPOSOMES WITH LIPIDS HAVING AN ADVANTAGEOUS PKA-VALUE FOR RNA DELIVERY

IPC classification:
A61K 9/127, A61K 39/00, C12N 15/86
Applicant:
Novartis AG
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Multiple attorneys, GlaxoSmithKline
Agent:
Catherine Sampson, GlaxoSmithKline S.A.
Status:
PATENT GRANTED
EP16184271

VIRION-LIKE DELIVERY PARTICLES FOR SELF-REPLICATING RNA MOLECULES

IPC classification:
A61K 9/50, A61K 39/00, A61K 39/12, A61K 39/155, A61K 39/245, C12N 15/86, C12N 15/88
Applicant:
GlaxoSmithKline Biologicals SA
Agent:
Carpmaels & Ransford LLP
Agent:
Andrew John Sanderson, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature